Debate : Every HR+ve MBC should receive CDK 4/6 inhibitors Yes/no?
Advances in HER2 negative breast cancers- Diagnosis & Management
Chairpersons :
Dr. A K Malhotra, Dr. Shekhar Patil
Speaker :
Dr. Amol Dongre vs Dr. Sandeep Batra
Moderator :
Dr. D C Doval